SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001640334-17-000803
Filing Date
2017-05-01
Accepted
2017-04-28 18:45:51
Documents
1
Period of Report
2017-04-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K etbi_8k.htm 8-K 10874
  Complete submission text file 0001640334-17-000803.txt   12151
Mailing Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109
Business Address 2681 EAST PARLEYS WAY - SUITE 204 SALT LAKE CITY UT 84109 8013223401
EASTGATE BIOTECH CORP (Filer) CIK: 0001099574 (see all company filings)

IRS No.: 870639378 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52886 | Film No.: 17797907
SIC: 6799 Investors, NEC